Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled levofloxacin and colistin for treatment of ventilator-associated pneumonia
IRCT20100107003014N26Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of levofloxacin and colistin in ventilator-associated pneumonia (VAP), sponsored by Mazandaran University of Medical Sciences. Started Oct 2023; status: completed.
02
Drugs
levofloxacincolistin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20100107003014N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100107003014N26.